We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Novel Microbes Identified, Linked to Severe Diarrhea

By LabMedica International staff writers
Posted on 09 Jul 2014
Microorganisms have been identified that may trigger diarrheal disease and others that may protect against it, which were not widely linked to the condition previously. More...


Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries and there is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.

An international team of scientists led by those at the University of Maryland (College Park, MD, USA) surveyed the intestinal microbiota of 992 children from four under-developed countries in West Africa (The Gambia and Mali), East Africa (Kenya), and South Asia (Bangladesh). Stool samples were selected from a large case/control study of moderate-to-severe diarrhea in children aged less than five years. All samples were analyzed by traditional microbiological tests for known bacterial, viral, and eukaryotic pathogens.

DNA was isolated and extracted using the QIAamp DNA stool extraction kit (Qiagen; Venlo, The Netherlands). DNA was amplified using “universal” primers targeting the V1-V2 region of the 16S ribosomal ribonucleic acid (rRNA) gene, a small subunit of the ribosome, in bacteria. Both forward and reverse primers had a 5’ portion specific for use with FLX sequencing technology (454 Life Sciences; Branford, CT, USA).

The scientists identified statistically significant disease associations with several organisms already implicated in diarrheal disease, such as members of the Escherichia/Shigella genus and Campylobacter jejuni. They also found that organisms not widely believed to cause the disease, including Streptococcus and Granulicatella, correlated with the condition in their study. In addition, the study revealed that the Prevotella genus and Lactobacillus ruminis may play a protective role against diarrhea. In almost 50% of the children examined with diarrhea, the condition could not be attributed to a specific causal pathogen. The team also found numerous children carrying Shigella, which is known to cause problems, yet the children showed no signs of moderate to severe diarrhea.

The authors concluded that their analysis of the 16S rRNA gene-based taxonomic profile of diarrheal and control stool samples demonstrated a strong association between acute diarrheal disease and the overall taxonomic composition of the stool microbiota in young children from the developing world. O. Colin Stine, PhD, a professor and senior author of the study said, “We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea.” The study was published on June 27, 2014, in the journal Genome Biology.

Related Links:

University of Maryland
454 Life Sciences



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers found that tumor DNA fragments in blood can reveal ongoing prostate cancer growth even when current tests show little change (image credit: Adobe Stock)

Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer

Prostate cancer is the most common cancer in the U.K., with more than 64,000 men diagnosed and 12,000 deaths each year. For the roughly 10,000 men annually with advanced disease, early assessment of treatment... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.